These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8188090)

  • 1. Characterization of peripheral blood and ovarian cancer-infiltrating lymphocytes: effect of HIV infection on phenotypic expression and proliferative response.
    Guidozzi F; Reddy S; Wadee A
    Gynecol Oncol; 1994 May; 53(2):251-5. PubMed ID: 8188090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
    Lomalisa P; Smith T; Guidozzi F
    Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients.
    Schöndorf T; Engel H; Kurbacher CM; Brenne U; Kolhagen H; Göhring UJ; Scharl A; Mallmann P
    J Soc Gynecol Investig; 1998; 5(2):102-7. PubMed ID: 9509389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
    Lorenzo JI; Molina R; Aznar JA
    Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute pneumonia and cell-mediated immunity in patients with HIV infection].
    Luzzati R; Cazzadori A; Malena M; Mazzi R; Danzi MC; Ciaffoni S; Concia E; Bassetti D
    Minerva Med; 1993 Mar; 84(3):95-101. PubMed ID: 8492971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin polymorphism in human immunodeficiency virus infection: Hp0 phenotype limits depletion of CD4 cell counts in HIV-1-seropositive individuals.
    Quaye IK; Brandful J; Ekuban FA; Gyan B; Ankrah NA
    J Infect Dis; 2000 Apr; 181(4):1483-5. PubMed ID: 10762581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
    Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
    J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
    Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.
    Dadmarz RD; Ordoubadi A; Mixon A; Thompson CO; Barracchini KC; Hijazi YM; Steller MA; Rosenberg SA; Schwartzentruber DJ
    Cancer J Sci Am; 1996; 2(5):263-72. PubMed ID: 9166543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of human immunodeficiency virus on local immunity in children with diarrhoea.
    Kakai R; Bwayo JJ; Wamola IA; Ndinya-Achola JO; Plummer FA
    East Afr Med J; 1995 Nov; 72(11):699-702. PubMed ID: 8904058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya.
    Temmerman M; Nagelkerke N; Bwayo J; Chomba EN; Ndinya-Achola J; Piot P
    AIDS; 1995 Sep; 9(9):1057-60. PubMed ID: 8527078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
    Melioli G; Ferrari I; Casartelli G; Ragni N
    Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes.
    Ikarashi H; Fujita K; Takakuwa K; Kodama S; Tokunaga A; Takahashi T; Tanaka K
    Cancer Res; 1994 Jan; 54(1):190-6. PubMed ID: 8261438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
    Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
    Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effect of serum in patients with ovarian carcinoma.
    Ueda K; Toyokawa M; Nakamori H; Sako H; Umesaki N; Nakade J; Lee T; Sugawa T
    Obstet Gynecol; 1978 Feb; 51(2):225-8. PubMed ID: 304546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.